GLEN HUANG
LOS ANGELES, CA
Browse related groups: CA Melinta Therapeutics, Inc. All categories
This page merges CMS profile IDs: 8800905, 9682778 (associated profiles published by CMS for the same provider; see the provenance section below).
General Payments — all program years on this page
$507.29
- Category: General Payments
- Program years: PY2020–2021
- Record count: 6
- As of (CMS publication): 2026-01-23
Latest program year (PY2021): $453.26 across 4 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2021) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $373.27 | 3 |
| Education | $79.99 | 1 |
By paying entity
Latest program year (PY2021) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Melinta Therapeutics, Inc. | $149.61 | 1 |
| Paratek Pharmaceuticals, Inc. | $119.09 | 1 |
| La Jolla Pharmaceutical Company | $104.57 | 1 |
| Astellas Pharma US Inc | $79.99 | 1 |
By program year
Records — PY2021 (4)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 806840205 | La Jolla Pharmaceutical Company | $104.57 | 04/21/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 813507791 | Paratek Pharmaceuticals, Inc. | $119.09 | 05/04/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 821372467 | Astellas Pharma US Inc | $79.99 | 06/16/2021 | Education | Undisputed | 01/23/2026 | View at CMS |
| 846744733 | Melinta Therapeutics, LLC | $149.61 | 05/25/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
- Merged CMS profile IDs: 8800905, 9682778
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.